Skip to main content
RVPH logo

RVPH · Reviva Pharmaceuticals Holdings, Inc. · Investor Relations

Track RVPH — free
$0.39 +0.04 (+10.76%) At close · May 14
Market Cap
$6.33M
Shares
13.11M
Volume · May 14 742.02K Avg daily vol (48 sessions) 985.8K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-29 Lytham Partners Fall 2026 Investor Conference Conference
2026-06-24 OTC Life Sciences Virtual Investor Forum Event
2026-06-22 BIO International Convention Event
2026-05-28 Lytham Partners Spring 2026 Investor Conference Conference
2026-05-20 A.G.P. Annual Healthcare Company Showcase Event
2026-04-27 Reviva Pharmaceuticals (RVPH) Fireside Chat: Developing brilaroxazine a novel dual-modulator for multiple neuropsychiatric indication including schizophrenia, bipolar disorder, and depression Webcast
2026-01-15 Lytham Partners 2026 Investor Healthcare Summit Webcast
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2026-01-11 Sachs 9th Annual Neuroscience Innovation Forum Event
2025-11-03 Spartan Capital Securities Second Annual Investor Conference Conference
2025-11-02 CNS Summit 2025 Poster Presentation Presentation
2025-10-10 KOL Webinar Hosted by Alliance Global Partners Event
2025-10-09 Roth Healthcare Opportunities Conference Conference

Source: https://revivapharma.com/investors/

Key facts CIK 1742927 CUSIP 76152G209 13F (30d) 1 filings 1 filers Visit website Investor relations